Insider filing · MRVI

Gregory T Lucier bought $369K of Maravai Lifesciences (MRVI)

Executed Dec 5 2025, disclosed Dec 9 2025, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Dec 9 2025), the stock returned +6.9% (delay-adjusted); from the execution session (Dec 5 2025), +4.3%. Derived: entry at the session's open, exit at the close 20 sessions later.

GL Gregory T Lucier Director profile →

Gregory T Lucier (Director) filed 5 Form 4 reports in the trailing twelve months (4 purchases, 1 sale), most often in DENTSPLY SIRONA Inc. (XRAY). Across 4 priced purchase filings, the average 21-session return was -10.6% from execution and -8.4% from disclosure (delay-adjusted; derived). The largest single filing was $916K of XRAY (82,200 sh × $11.14, as filed), executed Dec 8 2025.

MRVI MRVI MRVI · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→